209 related articles for article (PubMed ID: 25435423)
41. Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells.
Wagner R; Stübiger G; Veigel D; Wuczkowski M; Lanzerstorfer P; Weghuber J; Karteris E; Nowikovsky K; Wilfinger-Lutz N; Singer CF; Colomer R; Benhamú B; López-Rodríguez ML; Valent P; Grunt TW
Oncotarget; 2017 Feb; 8(7):11600-11613. PubMed ID: 28086243
[TBL] [Abstract][Full Text] [Related]
42. A Pilot Immunohistochemical Study Identifies Hedgehog Pathway Expression in Sinonasal Adenocarcinoma.
Leović M; Jakovčević A; Mumlek I; Zagorac I; Sabol M; Leović D
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731849
[TBL] [Abstract][Full Text] [Related]
43. A new mechanism of trastuzumab resistance in gastric cancer: MACC1 promotes the Warburg effect via activation of the PI3K/AKT signaling pathway.
Liu J; Pan C; Guo L; Wu M; Guo J; Peng S; Wu Q; Zuo Q
J Hematol Oncol; 2016 Aug; 9(1):76. PubMed ID: 27581375
[TBL] [Abstract][Full Text] [Related]
44. Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancer.
Zuo M; Rashid A; Churi C; Vauthey JN; Chang P; Li Y; Hung MC; Li D; Javle M
Br J Cancer; 2015 Mar; 112(6):1042-51. PubMed ID: 25742482
[TBL] [Abstract][Full Text] [Related]
45. FGF2 regulates proliferation, migration, and invasion of ECA109 cells through PI3K/Akt signalling pathway in vitro.
Shi H; Xu J; Zhao R; Wu H; Gu L; Chen Y
Cell Biol Int; 2016 May; 40(5):524-33. PubMed ID: 26833879
[TBL] [Abstract][Full Text] [Related]
46. PI3K-mTORC2 but not PI3K-mTORC1 regulates transcription of HIF2A/EPAS1 and vascularization in neuroblastoma.
Mohlin S; Hamidian A; von Stedingk K; Bridges E; Wigerup C; Bexell D; Påhlman S
Cancer Res; 2015 Nov; 75(21):4617-28. PubMed ID: 26432405
[TBL] [Abstract][Full Text] [Related]
47. Hedgehog pathway activation in T-cell acute lymphoblastic leukemia predicts response to SMO and GLI1 inhibitors.
Dagklis A; Demeyer S; De Bie J; Radaelli E; Pauwels D; Degryse S; Gielen O; Vicente C; Vandepoel R; Geerdens E; Uyttebroeck A; Boeckx N; de Bock CE; Cools J
Blood; 2016 Dec; 128(23):2642-2654. PubMed ID: 27694322
[TBL] [Abstract][Full Text] [Related]
48. The mammalian target of rapamycin complex 1 (mTORC1) in breast cancer: the impact of oestrogen receptor and HER2 pathways.
Jerjees DA; Negm OH; Alabdullah ML; Mirza S; Alkaabi M; Hameed MR; Abduljabbar R; Muftah A; Nolan CC; Green AR; Tighe PJ; Band V; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2015 Feb; 150(1):91-103. PubMed ID: 25701120
[TBL] [Abstract][Full Text] [Related]
49. Sonic hedgehog-Gli1 signals promote epithelial-mesenchymal transition in ovarian cancer by mediating PI3K/AKT pathway.
Ke Z; Caiping S; Qing Z; Xiaojing W
Med Oncol; 2015 Jan; 32(1):368. PubMed ID: 25432698
[TBL] [Abstract][Full Text] [Related]
50. miRNA-150 downregulation promotes pertuzumab resistance in ovarian cancer cells via AKT activation.
Wuerkenbieke D; Wang J; Li Y; Ma C
Arch Gynecol Obstet; 2015 Nov; 292(5):1109-16. PubMed ID: 25986891
[TBL] [Abstract][Full Text] [Related]
51. Emerging therapeutic targets in bladder cancer.
Carneiro BA; Meeks JJ; Kuzel TM; Scaranti M; Abdulkadir SA; Giles FJ
Cancer Treat Rev; 2015 Feb; 41(2):170-8. PubMed ID: 25498841
[TBL] [Abstract][Full Text] [Related]
52. Blocking signaling at the level of GLI regulates downstream gene expression and inhibits proliferation of canine osteosarcoma cells.
Shahi MH; Holt R; Rebhun RB
PLoS One; 2014; 9(5):e96593. PubMed ID: 24810746
[TBL] [Abstract][Full Text] [Related]
53. Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma.
Po A; Silvano M; Miele E; Capalbo C; Eramo A; Salvati V; Todaro M; Besharat ZM; Catanzaro G; Cucchi D; Coni S; Di Marcotullio L; Canettieri G; Vacca A; Stassi G; De Smaele E; Tartaglia M; Screpanti I; De Maria R; Ferretti E
Oncogene; 2017 Aug; 36(32):4641-4652. PubMed ID: 28368412
[TBL] [Abstract][Full Text] [Related]
54. hnRNPM guides an alternative splicing program in response to inhibition of the PI3K/AKT/mTOR pathway in Ewing sarcoma cells.
Passacantilli I; Frisone P; De Paola E; Fidaleo M; Paronetto MP
Nucleic Acids Res; 2017 Dec; 45(21):12270-12284. PubMed ID: 29036465
[TBL] [Abstract][Full Text] [Related]
55. NES1/KLK10 promotes trastuzumab resistance via activation of PI3K/AKT signaling pathway in gastric cancer.
Tang L; Long Z; Zhao N; Feng G; Guo X; Yu M
J Cell Biochem; 2018 Aug; 119(8):6398-6407. PubMed ID: 29231994
[TBL] [Abstract][Full Text] [Related]
56. [Acyldepsipeptide 1 induces apoptosis in renal cancer cells by down-regulation of Gli and Bcl-2 via SHH pathway].
Xu S; DU C; Ma Z; Gao Y; Shi Q; Wang X; Zhang H; He D; Guo P
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Mar; 30(3):258-61, 265. PubMed ID: 24606742
[TBL] [Abstract][Full Text] [Related]
57. Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened.
Gonnissen A; Isebaert S; Haustermans K
Oncotarget; 2015 Jun; 6(16):13899-913. PubMed ID: 26053182
[TBL] [Abstract][Full Text] [Related]
58. Hedgehog/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia.
Kern D; Regl G; Hofbauer SW; Altenhofer P; Achatz G; Dlugosz A; Schnidar H; Greil R; Hartmann TN; Aberger F
Oncogene; 2015 Oct; 34(42):5341-51. PubMed ID: 25639866
[TBL] [Abstract][Full Text] [Related]
59. Requirement of Gαi1/3-Gab1 signaling complex for keratinocyte growth factor-induced PI3K-AKT-mTORC1 activation.
Zhang YM; Zhang ZQ; Liu YY; Zhou X; Shi XH; Jiang Q; Fan DL; Cao C
J Invest Dermatol; 2015 Jan; 135(1):181-191. PubMed ID: 25078664
[TBL] [Abstract][Full Text] [Related]
60. Hedgehog signaling activates a positive feedback mechanism involving insulin-like growth factors to induce osteoblast differentiation.
Shi Y; Chen J; Karner CM; Long F
Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4678-83. PubMed ID: 25825734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
